Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-20

FDA Approved: SIVEXTRO — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved Sivextro (tedizolid phosphate) from Merck as the original application for the treatment of acute bacterial skin and skin structure infections cause…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sivextro (tedizolid)

Snippet

ORIG AP for SIVEXTRO (TEDIZOLID PHOSPHATE)